Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 1059-1064, February 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirvish, S. S.
Right arrow Articles by Gelboin, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirvish, S. S.
Right arrow Articles by Gelboin, H. V.

Positional Specificity for Methyl-n-amylnitrosamine Hydroxylation by Cytochrome P-450 Isozymes Determined with Monoclonal Antibodies1

Sidney S. Mirvish2, Qin Huang, Chuan Ji3, Shuhe Wang, Sang S. Park and Harry V. Gelboin

Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105 [S. S. M., Q. H., C. J., S. W.], and Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 [S. S. P., H. V. G.]

Inhibitory monoclonal antibodies (MAbs) were used to determine the contribution of epitope-specific cytochrome P-450 isozymes in rat liver microsomes to hydroxylation of the esophageal carcinogen methyl-n-amylnitrosamine. These P-450-catalyzed reactions form 2-, 3-, 4-, and 5-hydroxymethyl-n-amylnitrosamine, formaldehyde (demethylation), and pentaldehyde (depentylation). With uninduced microsomes from male rats, MAb 1-68-11 inhibited 4-hydroxylation by 73% and demethylation by 46%. This indicated the major contribution of constitutive malespecific P-450 IIC11 to the metabolism. Inhibition studies with MAbs 2-66-3 and 1-91-3 indicated that P-450 IIB1 contributed 19% and IIE1 35% to demethylation. With uninduced microsomes from females, MAb 1-68-11 produced similar inhibitions to those in male rats, indicating that female-specific P-450 IIC12 (which is closely related to IIC11) also catalyzed 4-hydroxylation and demethylation. With microsomes from 3-methylcholanthrene-induced male rats, P-450 IA1 and/or IA2 were responsible for 60% of 3-hydroxylation and 40% of depentylation. With microsomes from phenobarbital-treated rats, P-450 IIB1 and IIB2 catalyzed all 6 reactions but especially 4-hydroxylation and depentylation, which were 50–75% inhibited by MAb 2-66-3. Microsomes from Aroclorinduced males behaved as if they were induced by both 3-methylcholanthrene and phenobarbital. After treatment with isoniazid (a P-450 IIE1 inducer), inhibition by MAb 1-91-3 indicated a 45% contribution of P-450 IIE1 to demethylation, and both P-450 IIE1 and IIB1 (or IIB2) appear to have been induced. A major finding with uninduced microsomes was the high specificity of MAb 1-68-11 for inhibiting 4-hydroxylation, indicating that P-450 IIC11 and IIC12 catalyzed most of this {omega}-1-hydroxylation. In microsomes from induced rats, the MAb inhibitions showed the role of the induced P-450 IA1 (or IA2), IIB1 (or IIB2), and IIE1 in methyl-n-amylnitrosamine hydroxylation at different positions, as well as the presence of P-450 IIC11. This study illustrates the usefulness of inhibitory MAbs for defining the contribution of individual P-450s to position-specific metabolism.

1 This study was supported by NIH Grants R01-CA-35628 and core Grant CA-36727 from the National Cancer Institute and core Grant ACS-Sig-16 from the American Cancer Society. Some of these results were presented at earlier meetings (25, 26).

2 To whom requests for reprints should be addressed.

3 Present address: Department of Biochemistry, Vanderbilt University, Nashville, TN 37203.

Received 8/ 9/90. Accepted 11/29/90.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
N. Brookman-Amissah, A. G. Mackay, and P. F. Swann
Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus
Carcinogenesis, January 1, 2001; 22(1): 155 - 160.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. C. Chen, X. Wang, G. Xu, L. Zhou, J. L. Vennerstrom, F. Gonzalez, H. V. Gelboin, and S. S. Mirvish
Depentylation of [3H-pentyl]Methyl-n-amylnitrosamine by Rat Esophageal and Liver Microsomes and by Rat and Human Cytochrome P450 Isoforms
Cancer Res., January 1, 1999; 59(1): 91 - 98.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.